thats correct. anteo did have a strong relationship with Merck. when covid hit both companies went in different directions.
merck is now trying a different approach. thats ok. I'm sure anteo won't get commercial deals with all the potential partners they are dealing with in life science and CET.
the thing about our lifescience program is we now have anteobind NXT, with a huge amount of data on cost saving and performance improvement. there is a webinar launch on the website discussing it or just look at the savings from the presentation yesterday
I'll burrow from j85's post
"Along with the real cost saving benefits shown in varying coupling methods. They may only be cents per test but when running or selling millions of these sort of tests the savings become significant. Also gives an idea as to what actual revenues may flow from this side of the company in due course."
and there is always chance they will re connect with Anteo. Wyon tried it without us and appear to be back close to a deal.
Add to My Watchlist
What is My Watchlist?
